Cycle Pharmaceuticals

Passionate about providing quality treatments & services. Everything we do is with patients & caregivers’ best interests at heart. Every single patient matters.

[OncLive.com @OncLive]

🚨 BREAKING 🚨: The @US_FDA has approved an orally disintegrating tablet formulation of nilotinib for select patients with CML #leusm #hematology #oncology

https://t.co/AU5MYz17Qw

[Cycle Pharmaceuticals @CyclePharma]

New treatment option for patients with Philadelphia chromosome‑positive chronic myeloid leukemia (Ph+ CML), designed to allow for concomitant use with proton pump inhibitors (PPIs) and H2 receptor antagonists (H₂RAs) and with no mealtime restrictions. https://t.co/6vaDQ3L1fv

[Cycle Pharmaceuticals @CyclePharma]

Join us live on Tuesday, June 9 | 11 am - 12 pm ET for our educational webinar:

Scientific Perspectives on Fumarate Transitions in MS: A Clinical Review of Monomethyl Fumarate (MMF) Data and Observations

Secure your place here 👉 https://t.co/70N8Lg8qOS

[Cycle Pharmaceuticals @CyclePharma]

Come and meet the new Metabolic team at booth 103-105 to learn more about how we are working to improve the care of patients in the field.

We look forward to seeing you there!

#GMDI2026 #GMDIConference #GMDI26

[NPKUA @NPKUA_Info]

We appreciate the support of @CyclePharma, a Gold Sponsor of our 2026 Living Our Best PKU Life Community Conference. We are grateful for their partnership!

📅 Have you registered? Save with early bird pricing when you register by 3/31: https://t.co/OfqvfG2nVp

[Cycle Pharmaceuticals @CyclePharma]

AAAAI Annual Meeting 2026 – that’s a wrap! 👏

These past few days have been filled with meaningful connections, insightful conversations, and of course, lots of fun. Thank you to everyone who came out and spent time with our immunology team.

[Cycle Pharmaceuticals @CyclePharma]

When we asked our team, “What does supporting Cycle Pharma’s rare disease mission mean to you?” the responses spoke volumes.

Today we spotlight those living with conditions that are often invisible to others, and stand with them throughout their journey.

#RareDiseaseDay

[Cycle Pharmaceuticals @CyclePharma]

We’re live at the AAAAI’s Annual Meeting 2026 in Philadelphia, PA!

Want to hear how we could help your patients?

Come over to booth 1545 and learn more about us and how we provide quality treatment and patient care in the field of immunology.

#AAAAI2026

[Cycle Pharmaceuticals @CyclePharma]

Only one week to go!

We are delighted to be attending the AAAAI’s 2026 Annual Meeting next week in Philadelphia, PA. Come and meet our immunology team at booth 1545 to learn more about how we are working to improve patient care in this field.

[NPKUA @NPKUA_Info]

We’re proud to highlight the Discovery Sponsors of our 2026 Scientific Conference: @Alltrna, Aptatek BioSciences, Inc., Aurora Therapeutics, @CyclePharma, @MazeInBiotech, Perseo Pharma and ZOIA Pharma.

We appreciate your commitment to advancing progress for our PKU community!

[Cycle Pharmaceuticals @CyclePharma]

News: We have extended our tender offer of Applied Therapeutics further to one minute following 11:59 p.m., ET, on January 29, 2026.

Read the full press release here: https://t.co/9yF3EmmDdH

[Cycle Pharmaceuticals @CyclePharma]

Christmas has landed at Cycle Pharma HQ! Here the team are embracing the festive season with plenty of decorations and sweet treats, excited for a wholesome month ahead!🎄🎁☃️

[Cycle Pharmaceuticals @CyclePharma]

Today is National #PKUAwarenessDay! We're proud to support the
#PKU community, celebrate progress and work toward better treatments.

You can support the National PKU Alliance by donating today at
https://t.co/gricu0WHNy.

#PKUAwareness #NPKUA #Phenylketonuria

[Cycle Pharmaceuticals @CyclePharma]

We’re excited to announce the launch of Cycle Pharma's first oncology product in the US, PHYRAGO™ (dasatinib) tablets, for the treatment of leukemia.

Read the press release: https://t.co/TH6joQoHyf

Read the full prescribing information: https://t.co/oKTWJZvzw3

[Cycle Pharmaceuticals @CyclePharma]

Last night, Cycle won Private Business of the Year 2025 at the @bdoaccountant #PrivateBusinessAwards!
We are honored to receive recognition for our mission to deliver life-changing treatments through technical expertise, innovation and care
#RareDisease #PatientFirst

[Cycle Pharmaceuticals @CyclePharma]

Join our webinar, Advancing Care in Alkaptonuria: Diagnosis and Treatment.

Date: September 29, 2025
Time: 8am PT 11am ET

Learn more and register https://t.co/8sXTlQcv97

[NPKUA @NPKUA_Info]

Make the most of the final days of summer with Punch for PKU, a national event that encourages individuals and families to spread PKU awareness one cup of punch at a time. It's simple and fun, just like a lemonade stand! Learn more: https://t.co/EOaBJALzWh

[Cycle Pharmaceuticals @CyclePharma]

We are thrilled to announce an exciting new partnership with Handa Therapeutics, LLC. This collaboration extends our expertise in caring for patients living with chronic conditions into oncology.
Read about the full announcement details here: https://t.co/5Prjr8UErt

[NPKUA @NPKUA_Info]

🍎🖍️Calling all kindergarten parents! We are excited to announce the launch of our new Kindergarten Kits, free for individuals with PKU. Starting school is a big step, and this kit is designed to support this new transition. Visit https://t.co/0bmgTRWRyp to request your kit!

[Cycle Pharmaceuticals @CyclePharma]

We had a great time at Camp PHEver last week! This event gives children and teens with PKU a place to come together and enjoy a classic camp experience while staying on track with necessary diet restrictions. Check out the campers' great work at our bracelet-making station!